title: Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
abstract: Actinic keratosis (AK), a common cutaneous lesion with the potential to transform into squamous cell carcinoma, has traditionally been treated with ablative and/or surgical procedures. Recently, a topical formulation combining 0.5% 5-fluorouracil with 10% salicylic acid (5-FU-SA) was introduced in Europe under the trade name Actikerall™ for the treatment of grade I/II AKs. In a single randomized phase III trial, 5-FU-SA was shown to be superior to diclofenac 3% gel in hyaluronic acid, as measured by the histological clearance of one defined lesion (72% vs. 59.1%) and by complete clinical clearance (55.4% vs. 32.0%). 5-FU-SA should be applied once daily to a total area of up to 25 cm(2), which may include the lesion(s) and a small area of surrounding skin (rim of healthy skin should not exceed 0.5 cm), for up to 12 weeks. The most common side effects are local inflammation and pruritus at the application site, and no serious adverse effects have been reported to date. Now commercially available in Canada, 5-FU-SA represents a patientapplied therapeutic option for the treatment of both overt and subclinical AKs.
authors.affiliation: MD/MBA/MPH Candidate at Yale University, New Haven, CT, USA; Baylor College of Medicine, Houston, TX, USA.
authors.forename: H P
authors.initials: HP
authors.lastname: Nguyen
authors.affiliation: Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada; Pacific Dermaesthetics, Vancouver, BC, Canada.
authors.forename: J K
authors.initials: JK
authors.lastname: Rivers
mesh_terms: D000287:Administration, Topical; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D055623:Keratosis, Actinic / Q000188:drug therapy* / Q000473:pathology; D020156:Salicylic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D012996:Solutions
chemical_list: D004338:Drug Combinations; D012996:Solutions; D020156:Salicylic Acid; D005472:Fluorouracil